Cronos Group Inc. (TSE:CRON – Get Free Report)’s stock price was up 6.5% on Thursday. The company traded as high as C$5.47 and last traded at C$5.25. Approximately 456,041 shares traded hands during trading, an increase of 183% from the average session volume of 160,973 shares. The stock had previously closed at C$4.93.
Wall Street Analyst Weigh In
Separately, TD increased their price objective on Cronos Group from C$5.50 to C$6.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Three investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of C$4.92.
View Our Latest Research Report on CRON
Cronos Group Stock Performance
The firm’s 50 day moving average price is C$4.64 and its 200-day moving average price is C$3.99. The company has a debt-to-equity ratio of 0.12, a current ratio of 16.18 and a quick ratio of 24.01. The firm has a market cap of C$1.93 billion, a price-to-earnings ratio of 27.53, a P/E/G ratio of 0.12 and a beta of 1.29.
Cronos Group (TSE:CRON – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported C$0.06 earnings per share for the quarter. The company had revenue of C$90.33 million for the quarter. Cronos Group had a return on equity of 6.46% and a net margin of 38.95%. On average, analysts anticipate that Cronos Group Inc. will post -0.26 earnings per share for the current year.
About Cronos Group
Cronos is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT and Lord Jones. For more information about Cronos and its brands, please visit: thecronosgroup.com.
Further Reading
- Five stocks we like better than Cronos Group
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.
